# Services for the Preclinical Development of Therapeutic Agents

> **NIH NIH N01** · SRI INTERNATIONAL · 2022 · $481,746

## Abstract

The Services for the Preclinical Development of Therapeutic Agents contract offers a collection of preclinical services to support the development of promising therapeutic candidates, including those for lead identification and development, chemistry and manufacturing, in vitro microbiological services; in vitro and in vivo preclinical safety, toxicology and biokinetics; and pre-clinical development planning and evaluation.

## Key facts

- **NIH application ID:** 10550990
- **Project number:** N01AI60011-P00016-9999-2
- **Recipient organization:** SRI INTERNATIONAL
- **Principal Investigator:** Jon Carl Mirsalis
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $481,746
- **Award type:** —
- **Project period:** 2006-09-15 → 2012-09-06

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10550990

## Citation

> US National Institutes of Health, RePORTER application 10550990, Services for the Preclinical Development of Therapeutic Agents (N01AI60011-P00016-9999-2). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10550990. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*